Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies
Authors:
- 21 February 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (10) , 6857-6873
Abstract
Introduction A comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies was performed to map the different risk factors and assess the causality for lung cancer. Methods Systematic reviews and meta-analyses of observational and interventional studies were reviewed based on PubMed, Embase, Web of Science, and Cochrane Library. Mendelian randomization analyses were conducted to validate the causal associations of those various exposures with lung cancer using summary statistics from 10 genome-wide association studies (GWAS) consortia and other GWAS databases in MR-Base platform. Results In the review of meta-analyses, 105 risk factors associated with lung cancer were identified from 93 articles. It was found that 72 risk factors were nominally significant (P < 0.05) associated with lung cancer. Mendelian randomization analyses were performed to analyze 36 exposures based on 551 SNPs and 4,944,052 individuals, finding that 3 exposures had a consistent risk/protective effect on lung cancer with the results of the meta-analysis. In Mendelian randomization anaylses, smoking (OR 1.44, 95% CI 1.18–1.75; P = 0.001) and blood copper (OR 1.14, 95% CI 1.01–1.29; P = 0.039) significantly associated with increased risk of lung cancer, whereas aspirin use (OR 0.67, 95% CI 0.50–0.89; P = 0.006) showed protective effects. Conclusion This study mapped putative associations of risk factors for lung cancer, revealing the causal hazard effect of smoking, blood copper, and the protective effect of aspirin use in the development of lung cancer. Clinical trial registry This study is registered with PROSPERO (CRD42020159082).Keywords
Funding Information
- National Natural Science Foundation of China (82022048)
- China National Science Foundation (201804020030)
This publication has 39 references indexed in Scilit:
- Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable EstimatorsAmerican Journal of Epidemiology, 2013
- Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's CarcinogenesisClinical and Translational Gastroenterology, 2013
- Instrumental Variable Estimation of Causal Risk Ratios and Causal Odds Ratios in Mendelian Randomization AnalysesAmerican Journal of Epidemiology, 2011
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer RiskAmerican Journal of Epidemiology, 2010
- Synthesis of observational studies should consider credibility ceilingsJournal of Clinical Epidemiology, 2009
- Statins and cancer: A systematic review and meta-analysisEuropean Journal of Cancer, 2008
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Smoking and Carcinoma of the LungBMJ, 1950